Mr. Francois Roberge reports

LSL PHARMA GROUP GRANTS SHARE OPTIONS

LSL Pharma Group Inc. has granted an aggregate of 625,000 share options to three new officers and employees of the corporation in accordance with the corporation's share option plan.

Each option is exercisable for one common share in the capital of LSL Pharma at a price of 37 cents per share. This is a normal-course grant that comprises part of the long-term compensation and employee retention incentives program provided by the corporation. Options will vest in three equal 12-month instalments commencing on Jan. 17, 2026, with all of the options expiring on Jan. 17, 2035.

About LSL Pharma Group Inc.

LSL Pharma is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceuticals, as well as natural health products in solid, semi-solid and liquid dosage forms.